Cardiovascular-Kidney-Metabolic healthcare framework: Perspective from Hong Kong.
作者信息
Lee Chiho, Tang Sydney Chi Wai, Lee Michael Kang Yin, Ng Ying Wai, Chan Johnny Wai Man, Chan Tak Mao
机构信息
Division of Endocrinology and Metabolism, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Division of Nephrology, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
出版信息
Chin Med J (Engl). 2025 Sep 5;138(17):2054-2056. doi: 10.1097/CM9.0000000000003748. Epub 2025 Aug 4.
Abstract
摘要
相似文献
1
Cardiovascular-Kidney-Metabolic healthcare framework: Perspective from Hong Kong.心血管-肾脏-代谢医疗保健框架：香港视角
Chin Med J (Engl). 2025 Sep 5;138(17):2054-2056. doi: 10.1097/CM9.0000000000003748. Epub 2025 Aug 4.
2
Experience of Hong Kong patients awaiting kidney transplantation in mainland China.香港患者在中国大陆等待肾移植的经历。
J Clin Nurs. 2007 Nov;16(11C):341-9. doi: 10.1111/j.1365-2702.2007.02070.x.
3
Incorporating the cardiovascular-kidney-metabolic health framework into the local healthcare system: a position statement from the Hong Kong College of Physicians.将心血管-肾脏-代谢健康框架纳入本地医疗系统：香港内科医学院的立场声明
Hong Kong Med J. 2025 Feb;31(1):58-64. doi: 10.12809/hkmj2412200. Epub 2025 Jan 24.
4
The Hong Kong Society of Rheumatology consensus recommendations for the management of gout.香港风湿病学会痛风管理共识建议。
Clin Rheumatol. 2023 Aug;42(8):2013-2027. doi: 10.1007/s10067-023-06578-9. Epub 2023 Apr 4.
5
The role of trust and habit in the adoption of mHealth by older adults in Hong Kong: a healthcare technology service acceptance (HTSA) model.信任和习惯在香港老年人采用移动健康技术中的作用：一个医疗技术服务接受（HTSA）模型。
BMC Geriatr. 2023 Feb 4;23(1):73. doi: 10.1186/s12877-023-03779-4.
6
Evaluating cost-effectiveness of 9-valent HPV vaccination for men who have sex with men by HIV status in Hong Kong.评估香港男男性行为者按艾滋病毒感染状况接种9价人乳头瘤病毒疫苗的成本效益。
Vaccine. 2025 Sep 17;63:127625. doi: 10.1016/j.vaccine.2025.127625. Epub 2025 Aug 22.
7
Equality and social determinants of spatial accessibility, availability, and affordability to primary health care in Hong Kong, a descriptive study from the perspective of spatial analysis.香港基本医疗服务的空间可达性、可及性和可负担性的平等性及社会决定因素：基于空间分析的描述性研究。
BMC Health Serv Res. 2022 Nov 17;22(1):1364. doi: 10.1186/s12913-022-08760-2.
8
Psychological Distress and Protective Behaviors During the COVID-19 Pandemic Among Different Populations: Hong Kong General Population, Taiwan Healthcare Workers, and Taiwan Outpatients.新冠疫情期间不同人群的心理困扰与保护行为：香港普通人群、台湾医护人员及台湾门诊患者
Front Med (Lausanne). 2022 Feb 15;9:800962. doi: 10.3389/fmed.2022.800962. eCollection 2022.
9
2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population.《2016年香港人群动脉粥样硬化性心血管疾病预防共识声明》
Hong Kong Med J. 2017 Apr;23(2):191-201. doi: 10.12809/hkmj165045.
10
Research on the spatial distribution characteristics and influencing factors of sports intangible cultural heritage in the Guangdong-Hong Kong-Macao Greater Bay Area.粤港澳大湾区体育非物质文化遗产的空间分布特征及影响因素研究
Sci Rep. 2025 Jul 25;15(1):27147. doi: 10.1038/s41598-025-10734-3.
本文引用的文献
1
Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome.心血管-肾脏-代谢综合征关键组成部分的全球负担
J Am Soc Nephrol. 2025 Mar 5. doi: 10.1681/ASN.0000000658.
2
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in 3 Chinese Cohorts.3个中国队列中心血管-肾脏-代谢综合征的患病率
JACC Asia. 2025 Jan 7;5(1):116-118. doi: 10.1016/j.jacasi.2024.10.016. eCollection 2025 Jan.
3
Characteristics of patients with undiagnosed stage 3 chronic kidney disease: results from an observational study (REVEAL-CKD) in China.未诊断的3期慢性肾脏病患者的特征：中国一项观察性研究（REVEAL-CKD）的结果
Lancet Reg Health West Pac. 2025 Jan 4;54:101275. doi: 10.1016/j.lanwpc.2024.101275. eCollection 2025 Jan.
4
Incorporating the cardiovascular-kidney-metabolic health framework into the local healthcare system: a position statement from the Hong Kong College of Physicians.将心血管-肾脏-代谢健康框架纳入本地医疗系统：香港内科医学院的立场声明
Hong Kong Med J. 2025 Feb;31(1):58-64. doi: 10.12809/hkmj2412200. Epub 2025 Jan 24.
5
Early adulthood BMI and cardiovascular disease: a prospective cohort study from the China Kadoorie Biobank.成年早期体重指数与心血管疾病：来自中国嘉道理生物银行的一项前瞻性队列研究。
Lancet Public Health. 2024 Dec;9(12):e1005-e1013. doi: 10.1016/S2468-2667(24)00043-4. Epub 2024 Jun 15.
6
Trends in major non-communicable diseases and related risk factors in China 2002-2019: an analysis of nationally representative survey data.2002 - 2019年中国主要非传染性疾病及相关风险因素的趋势：基于全国代表性调查数据的分析
Lancet Reg Health West Pac. 2023 Jun 20;43:100809. doi: 10.1016/j.lanwpc.2023.100809. eCollection 2024 Feb.
7
Does the Healthy China 2030 Policy Improve People's Health? Empirical Evidence Based on the Difference-in-Differences Approach.《“健康中国2030”政策是否改善了人们的健康？基于双重差分法的实证证据》
Risk Manag Healthc Policy. 2024 Jan 6;17:65-77. doi: 10.2147/RMHP.S439581. eCollection 2024.
8
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.心血管-肾脏-代谢健康：美国心脏协会的总统顾问报告
Circulation. 2023 Nov 14;148(20):1606-1635. doi: 10.1161/CIR.0000000000001184. Epub 2023 Oct 9.
9
Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study.十年多学科风险评估和管理计划-糖尿病（RAMP-DM）对大血管和微血管并发症及全因死亡率的影响：一项基于人群的队列研究。
Diabetes Care. 2022 Dec 1;45(12):2871-2882. doi: 10.2337/dc22-0387.
10
Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18.中国城乡的体重指数和肥胖症：2004-2018 年连续全国代表性调查结果。
Lancet. 2021 Jul 3;398(10294):53-63. doi: 10.1016/S0140-6736(21)00798-4.
Zotero 插件